Organisation paid for research Program year 2025 Source: CMS Open Payments

California Research Foundation

Neither a doctor nor a teaching hospital

Research payments

$18,503,887

1,587 payments

Through program year 2025, California Research Foundation is reported as receiving $18,503,887 in research payments, across 1,587 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $2,239,194 58
2024 Research $1,188,701 198
2023 Research $3,047,009 315
2022 Research $2,175,920 449
2021 Research $5,733,854 207
2020 Research $3,568,962 196
2019 Research $550,247 164

Breakdown

Who paid Research payments · program years 2019–2025
  1. Pfizer Inc. $13,284,111 277 payments
  2. Sanofi Pasteur Inc. $1,766,051 93 payments
  3. Merck Sharp & Dohme Corporation $1,338,964 141 payments
  4. Moderna TX, Inc. $1,092,389 32 payments
  5. Seqirus USA Inc $410,424 396 payments
  6. GlaxoSmithKline, LLC. $317,735 30 payments
  7. Novo Nordisk AS $148,352 607 payments
  8. AstraZeneca Pharmaceuticals LP $100,784 6 payments
  9. AstraZeneca UK Limited $44,891 3 payments
  10. BioNTech SE $185 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Phase 123 Placebocontrolled Randomized Observerblind Dosefinding Study to Evaluate the Safety Tolerability Immunogenicity and Efficacy of Sarscov2 Rna Vaccine Candidates Against Covid19 in Healthy Adults $7,932,683 79 payments
  2. A Phase 3 Master Protocol to Evaluate Additional Doses of Bnt162b2 in Healthy Individuals Previously Vaccinated With Bnt162b2 $1,908,123 17 payments
  3. A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $1,414,049 48 payments
  4. A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults $807,968 13 payments
  5. A Phase 1 Randomized Study to Evaluate the Safety Tolerability and Immunogenicity of Combined Modified Rna Vaccine Candidates Against Covid19 and Influenza in Healthy Individuals $772,094 15 payments
  6. Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adults Aged 18 Years and Older $472,114 2 payments
  7. A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly with Influenza Vaccine in Adults 50 Years of Age or Older $469,509 6 payments
  8. An Interventional Randomized Activecontrolled Phase 23 Study to Investigate the Safety Tolerability and Immunogenicity of Bivalent Bnt162b Rnabased Vaccine Candidates As A Booster Dose in Covid19 Vaccineexperienced Healthy Individuals $448,981 18 payments
  9. A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Concomitant Administration of Either 23-Valent Pneumococcal Polysaccharide Vaccine or 15-Valent Pneumococcal Conjugate Vaccine with a Booster Dose of SARS-CoV-2 mRNA Vaccine in Healthy Adults 50 Years of Age or Older. $440,309 6 payments
  10. Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) in Children and Adolescents Aged 9 to 17 Years and Adults Aged 18 to 49 Years. $297,007 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record